About Contact Us Careers
Sign In

Asia Pacific Alzheimer Diagnosis and Treatment Market Size & Share, by Treatment (Drug Treatment, Non-Drug Treatment); Diagnosis Method (CT Scan, Magnetic Resonance (MRI), PET Scan, Electroencephalography (EEG), Cerebrospinal Fluid (CSF) Test); Treatment Provider (Hospitals, Specialty Clinics, Home Care); Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4692
  • Published Date: Feb 21, 2023
  • Report Format: PDF, PPT
  1. An Outline of the Alzheimer's Diagnosis and Treatment Market
    1. Market Definition
    2. Market Segmentation
    3. Product Overview
  2. Assumptions and Abbreviations
  3. Research Methodology & Approach
  4. Summary of the Report for Key Decision Makers
  5. Forces of the Market Constituents
    1. Factors/Drivers Impacting the Growth of the Market
    2. Market Trends for Better Business Practices
  6. Key Market Opportunities for Business Growth
  7. Major Roadblocks for the Market Growth
  8. Decarbonization Strategy and Carbon Credit Benefits for Market Players
    1. Global Government Decarbonization Plans/Goals by Each Country under 2015 Agreement Agreed by 200 Countries
    2. Measures taken by Countries to Reduce Carbon Footprints
    3. Carbon Credits and Subsidy Plans/Benefits Rolled out by the Government for Market Players
    4. Effective Ways to Harness Carbon-Credits and Impact on Profit Margins
    5. Demand Impact on the Companies Opting for Carbon Credits
  9. Government Regulation
  10. Industry Risk Analysis
    1. Demand Side
    2. Supply Side
  11. Industry Pricing Benchmarking & Analysis
  12. Global Economic Outlook: Challenges for Global Recovery and its Impact on Asia-Pacific Alzheimer's Diagnosis and Treatment Market
    1. Ukraine-Russia Crisis
    2. Potential US Economic Slowdown
  13. Pipeline Analysis Based on Alzheimer's Drugs
  14. Impact of COVID-19 on Asia Pacific Alzheimer's Diagnosis and Treatment Market
  15. Industry Growth Outlook W.R.T Treatment Type
  16. Industry Supply Chain Analysis
  17. Analysis on Recent Developments in the Alzheimer's and Dementia Diagnosis Kits
  18. Epidemiology Analysis on Dementia Associated with Alzheimer's Disease
  19. Analysis on the Alzheimer's Progression
  20. Competitive Positioning
  21. Competitive Model: A Detailed Inside View for Investors
    1. Market Share of Major Companies Profiled, 2022
    2. Business Profiles of Key Enterprises
      1. Eisai Co., Ltd.
      2. Biogen Inc.
      3. Eli Lilly and Company
      4. AbbVie Inc.
      5. Merz Pharma GmbH & Co. KGaA
      6. TauRx Therapeutics Ltd.
      7. Siemens Healthcare Private Limited
      8. Lupin Pharmaceuticals, Inc.
      9. Alkem Laboratories Ltd.
      10. Sun Pharmaceutical Industries Ltd.
    3. Japanese Players:
      1. Daiichi Sankyo Company Limited
      2. Sysmex Corporation
  22. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
      1. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
        1. Drug Treatment, 2022-2033F (USD Million)
          1. Cholinesterase Inhibitors, 2022-2033F (USD Million)
          2. NMDA Receptor Antagonists, 2022-2033F (USD Million)
          3. Other Therapeutics, 2022-2033F (USD Million)
        2. Non-Drug Treatment, 2022-2033F (USD Million)
          1. Cognitive Stimulation, 2022-2033F (USD Million)
          2. Aromatherapy, 2022-2033F (USD Million)
          3. Others, 2022-2033F (USD Million)
      2. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
        1. CT Scan, 2022-2033F (USD Million)
        2. Magnetic resonance imaging (MRI), 2022-2033F (USD Million)
        3. PET Scan, 2022-2033F (USD Million)
        4. Electroencephalography (EEG), 2022-2033F (USD Million)
        5. Cerebrospinal Fluid (CSF) Test, 2022-2033F (USD Million)
        6. Others, 2022-2033F (USD Million)
      3. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
        1. Hospitals, 2022-2033F (USD Million)
        2. Specialty Clinics, 2022-2033F (USD Million)
        3. Home Care, 2022-2033F (USD Million)
      4. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
        1. Hospitals Pharmacy, 2022-2033F (USD Million)
        2. Retail Pharmacy, 2022-2033F (USD Million)
        3. Online Pharmacy, 2022-2033F (USD Million)
      5. Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Country, 2022-2033
        1. India, 2022-2033F (USD Million)
        2. China, 2022-2033F (USD Million)
        3. Japan, 2022-2033F (USD Million)
        4. Australia, 2022-2033F (USD Million)
        5. Singapore, 2022-2033F (USD Million)
        6. Taiwan, 2022-2033F (USD Million)
        7. Vietnam, 2022-2033F (USD Million)
        8. South Korea, 2022-2033F (USD Million)
        9. Rest of Asia Pacific, 2022-2033F (USD Million)
  23. India Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
      1. India Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
        1. Drug Treatment, 2022-2033F (USD Million)
          1. Cholinesterase Inhibitors, 2022-2033F (USD Million)
          2. NMDA Receptor Antagonists, 2022-2033F (USD Million)
          3. Other Therapeutics, 2022-2033F (USD Million)
        2. Non-Drug Treatment, 2022-2033F (USD Million)
          1. Cognitive Stimulation, 2022-2033F (USD Million)
          2. Aromatherapy, 2022-2033F (USD Million)
          3. Others, 2022-2033F (USD Million)
      2. India Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
        1. CT Scan, 2022-2033F (USD Million)
        2. Magnetic resonance imaging (MRI), 2022-2033F (USD Million)
        3. PET Scan, 2022-2033F (USD Million)
        4. Electroencephalography (EEG), 2022-2033F (USD Million)
        5. Cerebrospinal Fluid (CSF) Test, 2022-2033F (USD Million)
        6. Others, 2022-2033F (USD Million)
      3. India Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
        1. Hospitals, 2022-2033F (USD Million)
        2. Specialty Clinics, 2022-2033F (USD Million)
        3. Home Care, 2022-2033F (USD Million)
      4. India Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
        1. Hospitals Pharmacy, 2022-2033F (USD Million)
        2. Retail Pharmacy, 2022-2033F (USD Million)
        3. Online Pharmacy, 2022-2033F (USD Million)
  24. China Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
      1. China Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
      2. China Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
      3. China Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
      4. China Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  25. Japan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Japan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Japan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Japan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Japan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  26. Australia Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Australia Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Australia Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Australia Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Australia Alzheimer’s Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  27. Singapore Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Singapore Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Singapore Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Singapore Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Singapore Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  28. Taiwan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Taiwan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Taiwan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Taiwan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Taiwan Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  29. Vietnam Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Vietnam Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Vietnam Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Vietnam Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Vietnam Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  30. South Korea Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. South Korea Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. South Korea Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. South Korea Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. South Korea Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033
  31. Rest of Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment, 2022 to 2033
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Pricing Analysis
    4. Rest of Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment, 2022-2033
    5. Rest of Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Diagnosis Method, 2022-2033
    6. Rest of Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Treatment Provider, 2022-2033
    7. Rest of Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook & Projections, Opportunity Assessment by Therapeutic Distribution Channel, 2022-2033

Companies Dominating the Asia Pacific Alzheimer's Diagnosis and Treatment Landscape

top-features-companies
    • Sysmex Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Daiichi Sankyo Company Limited
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Laboratories Ltd.
    • Lupin Pharmaceuticals, Inc.
    • TauRx Therapeutics Ltd.
    • Merz Pharma GmbH & Co. KGaA
    • AbbVie Inc.
    • Siemens Healthcare Private Limited
    • Eli Lilly and Company
    • Biogen Inc. 
    • Eisai Co., Ltd.
Browse Key Market Insights with Data Illustration:

In the News

  • Sysmex Corporation announced the permission to manufacture and market HISCL -Amyloid 1-42 Assay Kit and the HISCL -Amyloid 1-40 Assay Kit in Japan. The Product uses the company's automated immunoassay system HISCL-5000/HISCL-800 (the "HISCL-Series") to measure A levels in the blood and help identify A buildup in the brain, a sign of Alzheimer's disease.

  • Biogen, Inc. along with Eisai Co., Ltd. Announced that approval of U.S. Food and Drug Administration for ADUHELM has been speed up. Moreover, in order to support access for all eligible patients, particularly for depressed- class of the populations, both the company created a number of programs. These programs seek to aid patients and their families in comprehending the illness, navigating the diagnosis process, obtaining culturally competent care, and managing the cost of treatment.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4692
  • Published Date: Feb 21, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of Alzheimer's disease, a growing population of elderly, higher drug development, and proactive efforts by the government to help the patients are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 14.6% over the forecast period, i.e., 2023-2033.

Lack of awareness regarding Alzheimer's disease, higher rate of drug failure, and long and expensive process of drug development is estimated to be the growth hindering factors for the market expansion.

The market in the China region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Lupin Pharmaceuticals, Inc., TauRx Therapeutics Ltd., Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Siemens Healthcare Private Limited, Eli Lilly and Company, Biogen Inc., and Eisai Co., Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by treatment, treatment provider, diagnosis method, distribution channel, and by region.

The PET scan segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying